Six variants of calmodulin-dependent protein kinase IIγ were isolated from a ferret-aorta smooth-muscle cDNA library. Variant G-2 is generated by a novel alternative polyadenylation, utilizing a site contained in an intron. The last 77 residues of the association domain are replaced with 99 residues of a unique sequence containing Src homology 3-domain-binding motifs, which alter catalytic activity. Variant C-2 has an eight-residue deletion in an ATP-binding motif and does not autophosphorylate 
INTRODUCTION
Calmodulin (CaM) kinases are a family of protein kinases that are activated by Ca 2+ and CaM. CaM-dependent protein kinase II (CaMKII) is a ubiquitous protein that has a variety of functions in fundamental cellular processes such as metabolism, cell cycle [1] , cell shape, gene transcription [2] and in the regulation of ion channel and cytoskeletal function (reviewed in [3] [4] [5] ). There are four CaMKII isoforms (α, β, γ and δ), each of which is encoded by separate genes. The expression of α and β isoforms is restricted to nervous tissues [6] , and their chemistry in vitro as well as their function in cells has been extensively studied. Important functional roles of the α and β isoforms in synaptic plasticity, learning and memory have been reported [7] . In contrast, the γ and δ isoforms are expressed in most tissues [8] , but very few studies have been carried out to understand their functional roles.
CaMKII consists of an N-terminal catalytic/regulatory domain, a central-linker domain containing variable regions and a C-terminal association domain. The insertion of variable regions within the association domain has also been reported recently [5] . The catalytic/regulatory and association domains show high sequence identity across isoforms. The interaction of association domains between monomers leads to the formation of large multimeric holoenzymes. Based on electron-microscopic reconstructions, the structure of CaMKIIα holoenzyme has been referred to alternatively as a 'hub-and-spoke' pattern [8, 9] or a 'gear and foot' pattern [10] .
The activity of CaMKII is regulated by autophosphorylation. Upon activation by Ca 2+ /CaM, Thr 286 (numbering according to α isoform) is autophosphorylated. This autophosphorylation Abbreviations used: CaM, calmodulin; CaMKII, CaM-dependent protein kinase II; HRP, horseradish peroxidase; SH3, Src homology 3. 1 To whom correspondence should be addressed at Boston Biomedical Research Institute, 64 Grove Street, Watertown, MA 02472, U.S.A. (e-mail morgan@bbri.org).
The nucleotide sequences reported in this paper will appear in GenBank R Nucleotide Sequence Database under the accession numbers AF464182, AF464183, AF464184, AF464185, AF464186 and AF464187 for C-1, C-2, B, J, G-1 and G-2 variants respectively and with accession number AY099467 for the partial genomic sequence of ferret CaMKIIγ.
increases the affinity for Ca 2+ /CaM and also results in kinase activity in the absence of Ca 2+ /CaM. Thus autophosphorylation can lead to a prolonged kinase activity in response to a transient Ca 2+ signal. This property has been suggested to allow CaMKIIα to function as a decoder of Ca 2+ spike frequencies in cells and also to give the molecule a 'memory'. Two other sites, Thr 305 and Ser 314 , can be autophosphorylated in the α and β isoforms after the removal of Ca 2+ /CaM. Autophosphorylation at Thr 305 is inhibitory, but at Ser 314 it has no apparent effect on the affinity for CaM or kinase activity [11] .
We have reported previously [12] that a knockdown of CaMKIIγ with an antisense construct led to a significant inhibition of contractility in ferret-aorta smooth-muscle tissue. This study demonstrated a role for CaMKII in the regulation of contractility. The mechanisms involved, probably, multiple variants of CaMKIIγ , which could increase contractility by a number of putative actions, including the activation of extracellular-signal-regulated kinase and the subsequent activation of myosin light-chain kinase [13, 14] , direct phosphorylation of light chain 20 [15] and effects on channels [16, 17] .
The aim of the present study was to identify and characterize the CaMKIIγ variants in ferret aorta smooth muscle to gain insights into this ubiquitous, yet little understood, isoform. Thus we present the identification of six different variants of CaMKIIγ formed by alternative splicing and alternative polyadenylation of the same gene. Three of these variants are novel. Autophosphorylation, autodephosphorylation and exogenous substrate phosphorylation were found to differ markedly between variants, including one variant totally lacking in Thr 286 autophosphorylation. The functional differences have implications for important differences in cellular roles.
EXPERIMENTAL

Isolation of cDNAs of CaMKIIγ variants
Reverse transcriptase (RT)-PCR Total RNA was isolated from 100 mg of aorta by SV Total RNA isolation system (Promega). cDNA was synthesized using 1 µg of total RNA in a 20 µl reaction mixture for 1 h at 42
• C using an RT-PCR kit (ClonTech, Palo Alto, CA, U.S.A.). The reaction product was diluted to 100 µl, and 15 µl of the diluted cDNA was used in a PCR using two degenerate oligonucleotides: (1) sense, 5 -CCTGCACC(C/A)G(C/G)TTCAC(C/A)GA(C/A)GA-3 , and (2) antisense, 5 -T(G/C)A(G/A)(G/A)ATGGC(A/T)CCCTT (C/T/G)AG(T/C)TT-3 , for amino acids CTRFTDD and KLKGAIL respectively in the catalytic/regulatory domain of CaMKII. The PCR amplification was performed in a programmable thermal controller PTC-100 from MJ Research (Waltham, MA, U.S.A.), using a touchdown program as follows: 95
• C/30 s, 60-45
• C/45 s, 72
• C/1 min (16 cycles) followed by 30 cycles of 95
• C/30 s, 52
• C/1 min. A final extension at 72
• C was applied for 7 min. A product with approx. 900 bp was obtained; this was cloned into TOPO TA vector (Invitrogen, San Diego, CA, U.S.A.) and sequenced.
Screening of cDNA library
Total RNA was isolated from approx. 3 g of aorta using TRIzol R reagent from Gibco BRL (Gaithersburg, MD, U.S.A.). -specific RT-PCR-amplified cDNA was used as the probe in screening a ferret-aorta cDNA library [18] . The procedure followed was essentially identical with the manufacturer's instructions.
Cloning of genomic DNA for CaMKIIγ
Partial genomic DNA for CaMKIIγ was obtained by PCR amplification of ferret liver DNA, isolated by DNeasy tissue kit (Qiagen, Chatsworth, CA, U.S.A.), using two sets of primers: (i) sense, 5 -TAAGATCACAGAACAACTGAT-3 (P); antisense, 5 -CTGAAACTGCTTCTGGCTAACAGA-3 (S) and (ii) sense, 5 -AACCTCGTGGAGGGGATGGAT-3 (Q); antisense, 5 -ACCTCGGTACAGCAGAGACAGACACGA-3 (R). The positions of the primers are indicated by short arrows in Figure 3 .
Northern-blot analysis
RNA was isolated from ferret tissues using TRIzol R reagent (Gibco BRL). Total RNA (30 µg) was loaded on to an 11 cm × 9 cm agarose gel, containing formaldehyde and electrophoresed for 3 h. The gel was blotted to Zeta-Probe membrane (BioRad, Hercules, CA, U.S.A.) by a capillary transfer method using 10 × SSC (1 × SSC is 0.15 M NaCl/0.015 M sodium citrate). The membrane was UV-cross-linked and hybridized at 65
• C with a cDNA probe at high stringency.
Expression and FPLC fractionation of CaMKIIγ variants from COS7 cell lysates
The cDNA coding regions of CaMKIIγ variants were cloned into pcDNA4 His/Max TOPO vector (Invitrogen). Proteins were expressed in COS7 cells by transient transfection using LIPOFECTAMINE TM 2000 (Invitrogen). The expressed cell lysates, in a buffer containing 25 mM Pipes (pH 7.0), 0.2 M NaCl, 1 mM EGTA, 1 mM dithiothreitol and a phosphatase/protease inhibitor cocktail [19] , were loaded on to a Superose 12 (Amersham Biosciences) FPLC gel-filtration column and eluted with the same buffer. Fractions (250 µl) were collected and assayed for kinase activity using autocamtide-3 as described below; 3-4 fractions within a peak were pooled for experiments. The molecular masses of the fractions were calibrated using standards (BioRad) containing thyroglobulin (670 kDa), γ -globulin (158 kDa), ovalbumin (44 kDa), myoglobin (17 kDa) and vitamin B 12 (1.35 kDa), loaded under identical conditions. The positions of the elution of the standards are indicated in Figure 5 . In all cases, the 670 kDa fraction contained the CaMKII kinase activity. Western-blot analysis, using a CaMKII antibody, confirmed the presence of CaMKII in the fractions contained in the 670 kDa peak, but not in other fractions or in the 670 kDa fractions of untransfected COS7 cells. For all experiments, the CaMKII variants were normalized to give identical amounts of CaMKII, as identified by Western-blot analysis.
Autophosphorylation
Total autophosphorylation
FPLC-fractionated COS7 cell lysate (4 µg) for the B variant and equivalent amounts of other variants were autophosphorylated in a 50 µl reaction mixture, containing 50 mM Pipes (pH 7.0), 10 mM MgCl 2 , 0.5 mM CaCl 2 , 0.1 mg/ml BSA, 0.2 mM ATP and 25 µM [γ -
32 P]ATP. The protein stock contained a phosphatase/protease inhibitor cocktail consisting of 5.5 µM leupeptin, 5.5 µM pepstatin, 20 KIU (kallikrein-inhibitory units) of aprotinin, 20 µM 4-(2-aminoethyl)benzenesulphonyl fluoride, 2 mM Na 3 VO 4 , 1 mM NaF and 100 µM ZnCl 2 . To determine the CaM dependence of autophosphorylation, variable amounts of CaM (0-400 nM) were used as indicated in Figure 6 (A). For other autophosphorylation experiments, CaM was added to a final concentration of 400 nM. The reaction was incubated at 30
• C for the indicated time and stopped by the addition of SDS/PAGE loading buffer. For time course experiments, aliquots of 50 µl were withdrawn at the indicated time intervals, and the reaction was stopped. Phosphorylated proteins were electrophoresed on 10 % (w/v) polyacrylamide gel and the dried gel was exposed to a phosphor-imaging plate for 24 h. The band intensities were measured by Multianalyst software (Bio-Rad).
Thr 286 autophosphorylation
Thr 286 autophosphorylation was performed under the same conditions as described above, except for the use of unlabelled ATP and a CaM concentration of 400 nM. Phosphorylated products were resolved by SDS/PAGE [10 % (w/v) gel]. The gel was transferred on to a PVDF membrane (Millipore, Bedford, MA, U.S.A.) and bands were detected using an horseradish peroxidase (HRP)-coupled secondary antibody and ECL R reagent (Amersham); the image was developed on a phosphor-imaging plate. Intensities of bands were measured using Multianalyst software.
Antibodies
The 310-amino-acid catalytic/regulatory domain of CaMKIIγ was expressed in Escherichia coli, and a polyclonal antibody against this peptide was raised in rabbit (Capralogics, Hardwick, MA, U.S.A.). This antibody cross-reacted with all six variant proteins (pan CaMKIIγ ) and gave identical results with a commercially available CaMKIIγ antibody (Santa Cruz Biotechnology, Santa Cruz, CA, U.S.A.) raised in the goat against the C-terminal sequence of CaMKIIγ , with the exception of not recognizing CaMKIIγ G-2 that has a unique C-terminal sequence. Phospho-Thr 286 , the phospho-specific antibody, was purchased from Upstate Biotechnology (Lake Placid, NY, U.S.A.) and used at a dilution of 1 : 3000.
Substrate phosphorylation
Substrate phosphorylation was measured using an autocamtide-3 peptide [20] . The assay was performed in a 50 µl reaction mixture, containing 50 mM Pipes (pH 7.0), 10 mM MgCl 2 , 0.5 mM CaCl 2 , 0.1 mg/ml BSA, 5 µg/ml CaM, 20 µM autocamtide-3, 0.2 mM ATP and 25 µM [γ -
32 P]ATP. For kinase assays of FPLC fractions, 5 µl of each fraction was used after normalization for total protein by a Detergent Compatible protein assay (BioRad) followed by normalization for CaMKII content by Westernblot analysis. FPLC-fractionated CaMKIIγ B cell lysate (4 µg) and equivalent amounts of the other lysates were used. After incubation at 30
• C for 15 s, the reaction was stopped by the addition of trichloroacetic acid to a final concentration of 5 % and processed by spotting on P81 phosphocellulose paper. P81 papers were washed with water and Cerenkov radiation was counted in a liquid-scintillation counter. To determine the time course of substrate phosphorylation, 50 µl of the aliquots were withdrawn at indicated time intervals and spotted directly on P81 phosphocellulose paper and processed.
Two-dimensional gel electrophoresis
Ferret-aorta strips were strung up in an organ bath and tested for viability by contracting with 51 mM KCl physiological saline solution. The strips were then washed with normal physiological saline solution and allowed to relax for 1 h before being quick-frozen in a solid-CO 2 /acetone slurry, containing 10 mM dithiothreitol. The strips were homogenized in urea lysis buffer containing 9.5 M urea, 2.0 % (v/v) Nonidet P40, 5 % (v/v) 2-mercaptoethanol, 1.6 % (v/v) Pharmalyte 5-6 and 0.4 % Pharmalyte 3-10. The homogenate (10 µl) was loaded on to a tube gel (as per the Bio-Rad protocol for minigel format two-dimensional gels) followed by 5 µl of overlay buffer (9 M urea/0.8 % Pharmalyte 5-8/0.2 % Pharmalyte 3-10/0.005 % Bromophenol Blue). Protein samples were run on an isoelectricfocusing gel for the first dimension, followed by a 10 % SDS/polyacrylamide gel for the second dimension. Isoelectricfocusing gels contained 9.2 M urea, 4 % (w/v) acrylamide (total monomer), 2 % Nonidet P40, 1.6 % Pharmalyte 5-6, 0.4 % Pharmalyte 3-10, 0.01 % ammonium persulphate, 0.1 % N,N,N ,N -tetramethylethylenediamine. Gels were then transferred on to PVDF membranes and processed by Westernblot analysis. The CaMKII antibody raised against the catalytic domain and against the C-terminal sequences was used at 1 : 1000 and at 1 : 2000 dilution respectively. HRP-labelled secondary antibodies were used at 1 : 2000 dilution. Spots were visualized with ECL R (Supersignal CL-HRP Substrate System; Pierce, Rockford, IL, U.S.A.).
RESULTS
Cloning and characterization of CaMKIIγ subunit variants
CaMKII gene family members show a high degree of homology in their catalytic/regulatory domains. Based on this property, degenerate oligonucleotides were designed from the two ends of these regions. RT-PCR was performed on ferret aortic mRNA. As expected, one single band of approx. 900 bp was amplified. Of the 30 independent clones that were sequenced, 27 were γ and three were δ isoforms. A ferret aortic cDNA library was screened using one of the γ clones as a probe. Fourteen full-length cDNAs were obtained containing six different sequences, which we designated as the C-1, C-2, B, J, G-1 and G-2 variants. The alignment of the translated amino acid sequences is presented in Figure 1 . Structures of all six variants are represented diagrammatically in Figure 2 . Southern-blot analysis indicated a single copy gene in the genomic DNA (results not shown).
Alternative splicing of the CaMKIIγ gene in the variable region has been described in many different species (reviewed in [5, 8] ). We have adopted the nomenclature established by others [21] [22] [23] in naming the variants that we have isolated. The first reported γ variant, CaMKIIγ A , was identified to be brain-specific [24] . We did not detect the A variant. Nghiem et al. [22] described a human T-lymphocyte B variant, containing one variable domain. They also described a C variant, containing no variable domain. Singer et al. [21] reported a G variant containing two variable regions, V 1 and V 2 , in a porcine cDNA library. They also described the presence of a third variable region V 3 . In our six clones, we detected only V 1 and V 2 ( Figure 2 ). Three of our variants represent the ferret homologues of the B, C and G variants described previously, and we have named them as B, C-1 and G-1 respectively. (Simultaneously with the Singer et al. [21] report on the smooth-muscle G variant, a slightly different variant was isolated from tumour cells, but was also named variant G [25] .) The remaining three clones are novel variants. One clone contains the V 1 variable region, but not the V 2 region; thus, we have named it as J variant. The remaining two novel clones have variation in the conserved domains, and we have named them as variants C-2 and G-2. Variant G-2 differs from both the G variants described previously.
The C-2 variant is formed by alternative 3 splice site utilization and lacks part of the ATP-binding region
The C-2 variant has a stretch of eight amino acid residues deleted in the catalytic domain. This deletion overlaps with a part of the consensus motif involved in covering and anchoring the non-transferable phosphates of ATP [26] . The general consensus sequence for this region is (LIV)GxGx(FY)Gx(LIV) (where x represents any amino acid) [26] [27] [28] . The corresponding sequence for CaMKIIγ is LGKGAFSVV, which matches the consensus except that Gly at the seventh position has been replaced by Ser [24] . In the C-2 variant, GAFSVV and the subsequent two amino acids Arg-Arg are missing. Inspection of the sequence of the mature mRNA of the other variants indicated the presence of an alternative 3 site identified by an Ala-Gly, which was utilized as an acceptor in the production of the C-2 variant. As this variant, except for the eight-residue deletion, has the same sequence as variant C-1, we have designated it as CaMKIIγ C-2 .
Human CaMKIIγ gene sequence predicts the formation of a C-2 variant by utilization of an alternative 3 splice site
The human variants B and C are identical (100 % identity in the protein sequence and 95 % identity in the nucleotide sequence) with the ferret variants B and C-1 respectively, prompting us to analyse whether a similar alternative splicing site is present in the human gene. A comparison of the human genomic sequence (Hs10 − 24193: Homo sapiens chromosome 10 working draft sequence segment) with the cDNA sequence of human CaMKIIγ (accession no. L07044) revealed that there is an intron between the amino acids lysine and glycine in the ATP-binding region as is the case for the ferret gene. In addition, the 24 nt that are deleted in the ferret C-2 variant are identical in the human and ferret genes, including the AG at the splice consensus site. The use of this alternative 3 splice site would generate a human C-2 variant homologue.
Alternative polyadenylation leads to the formation of a novel association domain in the G-2 variant
The G-2 variant has the N-terminal 457 amino acids in common with variant G-1. This includes 88 amino acid residues in the association domain. However, the C-terminal stretch of 99 amino acids is unrelated to any CaMKII association domain in the databases. We have designated this variant as CaMKIIγ G-2 .
To investigate the origin of the novel sequence in the association domain of CaMKIIγ G-2 , the genomic sequence for that region from the ferret was determined. Oligonucleotides were designed from the novel cDNA sequence of variant G-2 and from the region that was identical across the remaining variants (short arrows in Figure 3A) . Inspection of the genomic organization ( Figure 3 and cDNA sequences revealed that the gene has two alternative polyadenylation sites (I and II) ( Figure 3A ). All variants except variant G-2 utilize the more of 3 site II, but variant G-2 utilized the more of 5 site, located in the intron (site I; Figure 3A) . Interestingly, a portion of this intron is retained in the mature mRNA, where it encodes a stretch of 99 amino acid residues (marked by the grey striped bar in variant G-2) in-frame with the preceding exon.
Three cis-acting elements in the mRNA sequence work together to determine the 3 -end cleavage and polyadenylation in mammalian pre-mRNA: (i) an AAUAAA (or, less frequently, an AUUAAA) motif which is usually present 10-30 nt but occasionally, up to 300 nt, upstream of the cleavage site; (ii) a lessconserved U-or GU-rich element which is present downstream of the cleavage site, approx. 30 nt downstream of the poly(A) + site; (iii) the cleavage site where polyadenylation occurs. The details of the transcription termination and polyadenylation mechanism have been reviewed by Zhao et al. [29] , Edwalds-Gilbert et al. [30] and Proudfoot [31] .
In the case of CaMKIIγ , the cis elements for the two alternative polyadenylation sites are quite different. For polyadenylation site I, we found an AAUAAA motif to be present 11 nt upstream of the polyadenylation site and a U-rich sequence 20-30 nt downstream of the polyadenylation site. In contrast, for polyadenylation site II, the AUUAAA motif is present 99 nt upstream of the cleavage site. Long distances between the AAUAAA motif and the cleavage site are accompanied typically by a stem and loop structure, which maintains the spacing required for the binding of the polyadenylation machinery [32] . Consistent with this, the polyadenylation site II sequence is predicted to form a stable stem and loop structure ( Figure 3A ).
The human CaMKIIγ gene sequence also contains a potential alternative polyadenylation site
The possible formation of a G-2 variant by the use of an alternative polyadenylation site in the human CaMKIIγ gene was also investigated. A 1775 bp intron is present in the human CaMKIIγ gene at the same site as that of the ferret 1475 bp intron (Figure 3 ). This intron also has an alternative polyadenylation site (AAUAAA), 1129 nt downstream of its 5 splice site. Interestingly, this intron encodes 104 amino acids in frame with the preceding exon if this alternative poly(A) + site is used to terminate transcription. The human and ferret amino acid sequences predicted from this region are 72 % identical in the first 37 amino acids and less similar in the remaining portion ( Figure 3B) .
The novel CaMKIIγ G-2 has a wide tissue distribution
To determine the tissue distribution of the G-2 variant containing a novel association domain, Northern-blot analysis was performed against total RNA of ferret tissues. For comparison, we first used a non-isoform-specific catalytic/regulatory region as a probe (Figure 4 ). This probe detected transcripts at the expected position of approx. 2 kb in high abundance in brain, but also in aorta, bladder, stomach and heart. No signal was detected from the liver. On the right panel of Figure 4 , the part of the association domain of variant G-2, which comes from the intron, was used as a probe. Signal was detected at the expected position of approx. 2.5 kb in brain, aorta, bladder, stomach and heart. No signal was detected in the liver. The absence of CaMKIIγ variants in the liver has been reported previously [6] .
CaMKIIγ G-2 , containing a novel association domain, forms oligomers
The association domain of CaMKII is known to be required for oligomer formation [3, 33, 34] . The unique sequence of the association domain of CaMKIIγ G-2 raises the question of whether this variant is capable of forming oligomers. The cDNAs of all variants were cloned into a mammalian expression vector (pcDNA4 His/Max TOPO) and expressed in COS7 cells by transient transfection. COS7 cell lysates were loaded on to a Superose-12 FPLC column [21] . The fractions eluted from the column were assayed for CaMK activity. Most of CaMKII kinase activity was present in the fractions corresponding to molecular masses in the range 600-700 kDa, thus indicating that all variants, including variant G-2, form oligomers containing 10-12 monomers ( Figure 5 ). This is consistent with models based on EM reconstruction of CaMKIIα oligomers [10, 35] .
The question arises as to the possible function of this novel sequence in the association domain of CaMKIIγ G-2 . Thus we performed a motif search (http://scansite.mit.edu/) and, at high stringency, the search identified two overlapping Src homology 3 (SH3)-binding motifs within this sequence. A PLCγ -like SH3-binding motif, LLPAPSPPLPLSLLT, centred at Pro 479 (score, 0.6) and a Grb2-like SH3-binding motif, ILLPAPSPPLPLSLL centred at Pro 478 (score, 0.5) were found. 
Autophosphorylation activity differs amongst CaMKIIγ variants
FPLC-purified COS7 lysates, containing equal amounts of CaMKII variants as judged by Western-blot analysis, were autophosphorylated in the presence of Ca 2+ and [γ -32 P]ATP at varying concentrations of CaM for 15 s, and samples were run on SDS/PAGE gels. Densitometry was performed on the autoradiograms and the band intensities, normalized to maximal intensity, were plotted against CaM concentration ( Figure 6A ). The different variants have similar CaM sensitivities, i.e. the 50 % maximal [CaM] are between 10 and 50 nM ( Figure 6A ). Since we found that 400 nM CaM approximates saturation for all variants, we have used this concentration for the subsequent studies.
The above results were normalized as a percentage of the response at 400 nM CaM. In contrast, for absolute values (at 400 nM CaM and 15 s of incubation with [γ -32 P]ATP; Figure 6B ), it was clear that the amount of autophosphorylation differed dramatically between the variants. Variants B and C-1 showed the highest level of autophosphorylation, variants G-1 and J showed an intermediate amount, and variants C-2 and G-2 showed very low autophosphorylation. A striking difference was seen between variants C-1 and C-2, which differ in sequence only by the deletion of eight residues in the catalytic domain of variant C-2. Also, variants B and G-1 differed considerably in the amount of autophosphorylation at 15 s, even though they differ in domain structure only by the addition of the variable region V1 to variant G-1.
The differences in the amount of 32 P incorporated into the variants at saturating [CaM] and at 15 s incubation suggest differences in either the speed or maximal extent of autophosphorylation. Thus autophosphorylation was monitored over a 600 s time course ( Figure 6C ). Clearly, there are differences among CaMKIIγ variants in the time course and also in the maximal extent of autophosphorylation. Variants B and G-1 approached a steady-state level of autophosphorylation by 600 s of incubation, at which time variant G-1 incorporates about half the amount of 32 P compared with that for variant B. This difference is especially of interest since the two variants differ by only one variable domain. A comparison of variant C-1 versus C-2, which differ only by the eight residues in the catalytic domain, indicates that variant C-2 autophosphorylates more slowly than does C-1. Figure 7 (B). Note that the Thr 286 autophosphorylation pattern for several variants is different from that for total 32 P incorporation ( Figure 6C ), indicating that phosphorylation at sites other than Thr 286 leads to the total 32 P incorporation. This is especially of interest, since the assay was performed in the presence of Ca 2+ /CaM and the likely sites, Thr 305 and/or Ser 314 , have been reported to be phosphorylated only after the removal of Ca 2+ /CaM [36] . Notably, CaMKIIγ J at 15 s has roughly the same or greater Thr 286 autophosphorylation as the B variant ( Figure 7B ) despite the fact that the B variant incorporated roughly twice the total 32 P at 15 s ( Figure 6C ). Thus the B variant must have a higher 32 P incorporation into sites other than Thr 286 . A similar conclusion can be reached with respect to the C-1 variant, which has far more total 32 P incorporation than the G-1 variant at 600 s, but less Thr 286 phosphorylation. Most surprisingly, under these experimental conditions, virtually no Thr 286 phosphorylation was observed at any given point of time for variant C-2 ( Figure 7B ), although it shows significant total autophosphorylation ( Figure 6C ). Thus autophosphorylation of variant C-2 must occur at sites other than Thr 286 .
Two CaMKIIγ variants containing a single variable domain undergo autodephosphorylation
The time course shown in Figure 7 for all variants indicates that phosphorylation at Thr 286 for variant B is high at 15 s but then decreases. This occurs despite the presence of high concentrations of phosphatase inhibitors. A similar but less dramatic profile was also seen for the J variant. The common factor in the B and J variants is that each possesses one variable domain. A similar reversal of autophosphorylation has been described previously for the α and β isoforms and has been referred to as autodephosphorylation [38] .
Substrate phosphorylation rates are dependent on the variation of domain structure, but do not correlate with autophosphorylation Autophosphorylation is a measure of kinase activity, but may differ in some aspects from the kinase activity towards an exogenous substrate. The C-2 variant showed no autophosphorylation at Thr 286 , but did show a slow phosphorylation at other sites. Thus the question arises whether this variant could phosphorylate an extrinsic substrate. Phosphorylation of a substrate peptide, autocamtide-3 [20] , was tested for all variants. This peptide has a sequence taken from the autophosphorylation motif of CaMKII. As shown in Figure 8 
Multiple variants of CaMKIIγ are expressed as protein in ferret-aorta tissue
The molecular masses of the variants range from 55 to 62 kDa, based on the sequence, and furthermore, they run at very similar positions on denaturing SDS/PAGE gels (as can be seen in Figures 6-8) . Hence, we used two-dimensional gels to obtain information on the maximum number of possible variants that are expressed as proteins in the tissue from which the cDNA sequences were isolated. Figure 9 illustrates a two-dimensional gel of whole-cell homogenate from ferret aorta, immunostained with an antibody raised against the conserved catalytic domain of CaMKIIγ C-1 (upper panel) and then re-probed with a second antibody raised against the C-terminal end of conserved Cterminal sequences and specific for γ over δ isoforms (lower panel). The aorta tissue was frozen quickly under resting conditions, previously shown to minimize autophosphorylation [12] . As can be seen, up to seven variants can be observed. Most of the spots recognized by the antibody raised against the catalytic domain were also recognized by the γ -specific antibody.
DISCUSSION
A major finding of the present study was the discovery of the CaMKII variant G-2, which is formed by an alternative polyadenylation mechanism and contains, as a result, a novel association domain. The DNA sequence for both ferret and human CaMKIIγ contains two alternative polyadenylation sites with specific cis-acting sequences for polyadenylation. Apparently, these two polyadenylation sites, of which one is contained in an intron are, however, regulated differentially to produce different variants. Thus CaMKIIγ diversity arises not only due to alternative splicing but also from the alternative polyadenylation.
Regarding the ability of the G-2 variant to oligomerize, it was surprising that, notwithstanding the novel association domain, this protein was still eluted in the same approx. 670 kDa fraction from a gel-filtration column as did the other variants, thus indicating that it can form a multimeric holoenzyme structure. We cannot rule out the possibility that a monomer of variant G-2 formed a complex with other proteins, but it seems unlikely that such a complex would also run exactly in the 670 kDa fraction. On the other hand, interaction of association domains of α and β isoforms has been studied previously by deletion mutation in yeast two-hybrid assay [39] , and it was determined that amino acid residues 382-427 and not 427-478 were essential for oligomer formation of the α subunit. The last 51 residues were said to contribute to the stability of the oligomer formation, but were not considered to be essential for oligomer formation [39] . Our results are consistent with the observations of Kolb et al. [39] in that the conserved 88 amino acid residues of the CaMKIIγ G-2 variant appear to be sufficient for subunit interaction and holoenzyme formation. It is of interest that the transcript for the G-2 variant is present in many different tissues in addition to aorta, from which it was cloned. Further work will be needed to determine the function of this novel 99-amino-acid sequence, but it is of interest that a motif search predicted the presence of two overlapping SH3-binding domains within these 99 amino acid residues. This suggests a possible role for this region in protein-protein interactions regulated by signal transduction pathways in cells.
Another major finding of the present study was the discovery of the C-2 variant that lacks part of the ATP-binding consensus sequence. This deletion in the catalytic/regulatory domain illustrates the fact that alternative splicing of CaMKIIγ can occur in the conserved domains as well as in the variable domain [40] . The study of kinase activity of this variant in comparison with its counterpart, the C-1 variant, showed that both autophosphorylation and phosphorylation of a substrate peptide were impaired significantly in variant C-2. Note that autophosphorylation at Thr 286 was undetectable in this variant. Given the important role of this autophosphorylation in the 'memory' of the molecule [8] , it is predicted that the function of the C-2 variant in cells would differ markedly from the function of CaMKII described previously.
The catalytic domain of all kinases has been described as containing 12 subdomains. Within the N-terminal segment of CaMKII, a consensus motif GxGxxGxV, typical of the majority of known protein kinases, has been described which contributes to the binding of ATP. This specific motif is thought to cover and anchor the non-transferable phosphates of ATP [26] . The deletion in this region in variant C-2 clearly leads to its decreased kinase activity. However, it is of interest that although variant C-2 displayed no detectable autophosphorylation at Thr 286 , it did incorporate significant 32 P into other autophosphorylation sites and did phosphorylate a substrate peptide that mimicked the sequence of the autophosphorylation site, albeit at a slower rate. The residual kinase activity is consistent with the fact that at least four additional segments preserved in variant C-2 are also thought to contribute to ATP binding. An invariant lysine residue of subdomain II has long been recognized as essential for maximal enzyme activity, and is considered to anchor and orient the ATP molecule. This residue is included in the sequence IVHRDLKPENLL, matching a conserved motif typical of most Ser/Thr protein kinases [41] , which is preserved in the C-2 variant. The binding of ATP is further stabilized by a glutamic residue of subdomain III. Hydrogen bonding to ATP also comes from residues in subdomains V, VI and VII. Thus in CaMKIIγ C-2 , though a part of subdomain I is deleted, these other interacting residues are preserved and, apparently, are sufficient for the C-2 variant to retain its kinase activity. The inability of the C-2 variant to autophosphorylate Thr 286 may be related to the fact that the reaction occurs between subunits in the holoenzyme and is therefore under greater steric constraint than is phosphorylation of a peptide substrate [42] . Presumably, this reaction is sterically unfavourable in the C-2 variant.
Our results also suggest that the ATP-recognition consensus sequence in CaMKII has an additional function to facilitate autophosphorylation of Thr 286 , possibly by contributing in some way to the monomer-monomer interaction. If this region is missing, no Thr 286 autophosphorylation is seen. This interpretation would be consistent with the results of Lengyel et al. [43] , showing that the addition of a synthetic peptide corresponding to this region inhibits autophosphorylation. The peptide in this case may disrupt an endogenous interaction between the subdomain I ATP-binding motif and the Thr 286 region. Thus taken together, these results suggest that the eight residues of the subdomain I ATP-binding motif and the autophosphorylation site may interact in the threedimensional structure of the enzyme even though they are distant from each other in the linear sequence.
We also observed in the present study that the insertion and deletion of variable domains into the sequence linking the catalytic/regulatory domain to the association domain leads to alteration in catalytic activity. It is clear that the association domains function in the formation of the holoenzyme structure, and the catalytic and regulatory domains directly control the phosphotransferase activity of the kinase, whereas the function of the variable domains is not clear. Variable domains might be thought of as simple 'spacers' that determine the length of the 'spoke' in the 'hub-and-spoke' holoenzyme model [8] . However, our study suggests that the organization of variable domains also affects the kinase activity of the catalytic domain. A change in the length of the 'spoke' could easily be imagined to cause an alteration in the interaction of the monomers within the holoenzyme and, hence, alter autophosphorylation activities. However, substrate peptide phosphorylation activities also varied with the organization of the variable domain. This suggests that the variable domain may interact with a part of the catalytic domain in the (as yet undetermined) three-dimensional structure of the CaMKII monomers.
A surprising observation was the 'autodephosphorylation' of variants B and J. A common feature of these two variants is that each possesses a single variable domain. This phenomenon has been reported only once before with respect to the α and β isoforms, and the mechanism was suggested to be a reversal of the kinase reaction [38] . Our study confirms this previous report and extends the observation to the γ isoform. However, the mechanism involving a simple product build-up and a driving of the reaction backwards, as proposed by Kim et al. [38] , does not appear sufficient to explain our results. In particular, the decrease in 32 P incorporated with time would require not only a reversal of the phosphorylation, which would lead only to a constant steadystate level of autophosphorylation, but also an inhibition of the forward rate after prolonged incubation. Only a combination of the two effects would lead to biphasic time-dependence as observed in Figure 7 . It is plausible that autophosphorylation at sites other than Thr 286 is responsible for this effect. Because of high sequence homology in the catalytic/regulatory domain in all CaMKII isoforms, it is expected that autophosphorylation will be regulated in a similar manner in all isoforms. As reported for the α and β isoforms, Thr 286 was autophosphorylated in the presence of Ca 2+ /CaM in CaMKIIγ , as detected with a phospho-specific antibody. However, our results also indicate that autophosphorylation at other sites of CaMKIIγ also occurs in the presence of saturating levels of Ca 2+ /CaM. Earlier studies using α and β CaMKII reported that autophosphorylation at Thr 305 and Ser 314 occurs only after the removal of Ca 2+ [36] . The fact that we observe autophosphorylation at sites other than Thr 286 in the presence of Ca 2+ /CaM could well be due to differences between the γ isoform and the α and β isoforms.
Thus we have described the in vitro function of six CaMKIIγ variants, three of which are novel and one is formed by a novel alternative polyadenylation. These variants differ in their kinase properties in ways that are likely to lead to functional differences in cells. The structure-function differences may also contribute to the yet to be determined three-dimensional structure of CaMKII.
